Pondering vexing issues in infection prevention and control
Tuesday, April 19, 2011
Show me the money
The IMS Institute for Healthcare Informatics recently released its 2010 report on the use of medications in the US (you can view it here). In the list of the top 25 prescribed drugs based on revenue generated, there is only one anti-infective, Atripla, which ranks #23. And you wonder why there are so few new antibiotics in development?
Subscribe to:
Post Comments (Atom)
OSHA! OSHA! OSHA!
In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati...
-
In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati...
-
This is a guest post by Jorge Salinas, MD, Hospital Epidemiologist at the University of Iowa Hospitals & Clinics. There is virtually no...
-
I’m surprised that we can’t stop arguing about the modes of SARS-CoV-2 transmission, despite the fact that most experts (including our frie...
No comments:
Post a Comment
Thanks for submitting your comment to the Controversies blog. To reduce spam, all comments will be reviewed by the blog moderator prior to publishing. However, all legitimate comments will be published, whether they agree with or oppose the content of the post.